Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has raised its shareholding in Zenotech Laboratories from 46.85% of pre rights issue capital to 57.56% of the post rights issue capital.

This is pursuant to allotment of 1,90,00,000 equity shares of Rs 10 each for cash at a price of Rs 45 each including a share premium of Rs 35 per equity share issued on rights basis by Zenotech.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.